Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.

Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...

A new study suggests a potential molecular strategy for treating fragile X syndrome, an inherited neurodevelopmental disorder that causes autism spectrum disorder and intellectual disability. This ...

Please provide your email address to receive an email when new articles are posted on . Cognitive recovery was greatest within the first 6 months of diagnosis, persisting up to 36 months. After the 36 ...